首页 > 最新文献

PCN reports : psychiatry and clinical neurosciences最新文献

英文 中文
Obsessive-compulsive disorder induced by donepezil in a patient with Alzheimer's disease. 多奈哌齐诱发阿尔茨海默病患者的强迫症。
Pub Date : 2024-06-17 eCollection Date: 2024-06-01 DOI: 10.1002/pcn5.217
Kohei Echizen, Daisuke Hirose

Background: Donepezil, an acetylcholinesterase inhibitor commonly used to treat Alzheimer's disease (AD), is generally well tolerated. There have been no previous reports on donepezil-induced obsessive-compulsive disorder (OCD).

Case presentation: The patient, a retired man in his 70s diagnosed with AD, displayed OCD symptoms following donepezil initiation, exacerbating post-stroke-specifically, a cerebral infarction in the right posterior limb of the internal capsule. Remarkably, the symptoms abated upon discontinuation of donepezil.

Conclusion: Caution should be exercised when using donepezil in patients with a history of stroke.

背景:多奈哌齐是一种乙酰胆碱酯酶抑制剂,常用于治疗阿尔茨海默病(AD),一般耐受性良好。以前没有关于多奈哌齐诱发强迫症(OCD)的报道:患者是一名 70 多岁的退休男子,被诊断患有 AD,在开始服用多奈哌齐后出现了强迫症症状,中风后症状加剧,特别是右侧内囊后肢脑梗塞。值得注意的是,这些症状在停用多奈哌齐后有所缓解:结论:对有中风病史的患者使用多奈哌齐时应谨慎。
{"title":"Obsessive-compulsive disorder induced by donepezil in a patient with Alzheimer's disease.","authors":"Kohei Echizen, Daisuke Hirose","doi":"10.1002/pcn5.217","DOIUrl":"https://doi.org/10.1002/pcn5.217","url":null,"abstract":"<p><strong>Background: </strong>Donepezil, an acetylcholinesterase inhibitor commonly used to treat Alzheimer's disease (AD), is generally well tolerated. There have been no previous reports on donepezil-induced obsessive-compulsive disorder (OCD).</p><p><strong>Case presentation: </strong>The patient, a retired man in his 70s diagnosed with AD, displayed OCD symptoms following donepezil initiation, exacerbating post-stroke-specifically, a cerebral infarction in the right posterior limb of the internal capsule. Remarkably, the symptoms abated upon discontinuation of donepezil.</p><p><strong>Conclusion: </strong>Caution should be exercised when using donepezil in patients with a history of stroke.</p>","PeriodicalId":74405,"journal":{"name":"PCN reports : psychiatry and clinical neurosciences","volume":"3 2","pages":"e217"},"PeriodicalIF":0.0,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11180973/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141422140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A systematic review of cognitive and behavioral tools to differentiate behavioral variant frontotemporal dementia from other conditions. 系统回顾用于区分行为变异型额颞叶痴呆症与其他疾病的认知和行为工具。
Pub Date : 2024-06-16 eCollection Date: 2024-06-01 DOI: 10.1002/pcn5.210
Joshua Flavell, Peter John Nestor

The behavioral variant of frontotemporal dementia (bvFTD) is thought to be the commonest clinical presentation of frontotemporal lobar degeneration and is predominantly characterized by changes in behavior. In patients lacking unequivocal biomarker evidence of frontotemporal neurodegeneration, the clinical diagnosis of bvFTD is often unstable. In response, we conducted a systematic review and critical appraisal of cognitive and behavioral tools that have sought to differentiate bvFTD from other conditions. A systematic literature review of PubMed, Scopus, and Web of Science was conducted on December 31, 2023 for cognitive and behavioral tools that differentiated bvFTD from other cohorts. Ninety-six studies were included. The quality appraisal of almost all studies was low and introduced a high risk of bias. The few studies that were of high quality had a prospective study design and recruited patients suspected (but not yet confirmed) to have bvFTD. These studies reported that behavioral tools (e.g., the Frontal Behavioral Inventory) and social cognition tests (e.g., the Ekman's Faces Test) had good test performance in differentiating bvFTD from a broad range of psychiatric and neurological conditions. Importantly, the review highlighted the extreme paucity of studies that have evaluated methods where, in Bayesian terms, there is genuine clinical uncertainty regarding a diagnosis of bvFTD. Most studies used healthy controls of typical Alzheimer's disease as comparators-groups that often have negligible pretest probability of bvFTD. In response, we propose a study design checklist for studies seeking to develop diagnostic algorithms in bvFTD research.

额颞叶痴呆行为变异型(bvFTD)被认为是额颞叶变性最常见的临床表现,主要以行为改变为特征。在缺乏额颞叶神经变性的明确生物标志物证据的患者中,bvFTD 的临床诊断往往不稳定。为此,我们对试图将 bvFTD 与其他疾病区分开来的认知和行为工具进行了系统性回顾和批判性评估。2023年12月31日,我们对PubMed、Scopus和Web of Science进行了系统性文献综述,研究将bvFTD与其他群组区分开来的认知和行为工具。共纳入 96 项研究。几乎所有研究的质量评估都较低,且存在较高的偏倚风险。少数质量较高的研究采用了前瞻性研究设计,并招募了疑似(但尚未确诊)患有 bvFTD 的患者。这些研究报告称,行为工具(如额叶行为量表)和社会认知测试(如埃克曼面孔测试)在区分 bvFTD 与各种精神和神经疾病方面具有良好的测试性能。重要的是,该综述强调,在贝叶斯术语中,对 bvFTD 诊断存在真正临床不确定性的情况下,评估方法的研究极少。大多数研究使用典型阿尔茨海默病的健康对照组作为对比组--这些对照组的 bvFTD 检测前概率往往微乎其微。为此,我们提出了一份研究设计清单,供在 bvFTD 研究中寻求开发诊断算法的研究使用。
{"title":"A systematic review of cognitive and behavioral tools to differentiate behavioral variant frontotemporal dementia from other conditions.","authors":"Joshua Flavell, Peter John Nestor","doi":"10.1002/pcn5.210","DOIUrl":"https://doi.org/10.1002/pcn5.210","url":null,"abstract":"<p><p>The behavioral variant of frontotemporal dementia (bvFTD) is thought to be the commonest clinical presentation of frontotemporal lobar degeneration and is predominantly characterized by changes in behavior. In patients lacking unequivocal biomarker evidence of frontotemporal neurodegeneration, the clinical diagnosis of bvFTD is often unstable. In response, we conducted a systematic review and critical appraisal of cognitive and behavioral tools that have sought to differentiate bvFTD from other conditions. A systematic literature review of PubMed, Scopus, and Web of Science was conducted on December 31, 2023 for cognitive and behavioral tools that differentiated bvFTD from other cohorts. Ninety-six studies were included. The quality appraisal of almost all studies was low and introduced a high risk of bias. The few studies that were of high quality had a prospective study design and recruited patients suspected (but not yet confirmed) to have bvFTD. These studies reported that behavioral tools (e.g., the Frontal Behavioral Inventory) and social cognition tests (e.g., the Ekman's Faces Test) had good test performance in differentiating bvFTD from a broad range of psychiatric and neurological conditions. Importantly, the review highlighted the extreme paucity of studies that have evaluated methods where, in Bayesian terms, there is genuine clinical uncertainty regarding a diagnosis of bvFTD. Most studies used healthy controls of typical Alzheimer's disease as comparators-groups that often have negligible pretest probability of bvFTD. In response, we propose a study design checklist for studies seeking to develop diagnostic algorithms in bvFTD research.</p>","PeriodicalId":74405,"journal":{"name":"PCN reports : psychiatry and clinical neurosciences","volume":"3 2","pages":"e210"},"PeriodicalIF":0.0,"publicationDate":"2024-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11180949/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141422139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obsessive-compulsive disorder after traumatic injury to the right frontal and left temporal lobes: A case report. 右额叶和左颞叶外伤后的强迫症:病例报告。
Pub Date : 2024-06-14 eCollection Date: 2024-06-01 DOI: 10.1002/pcn5.199
Daisuke Yoshioka, Takehiko Yamanashi, Teruaki Hayashi, Masaaki Iwata

Background: Obsessive-compulsive disorder (OCD) is a common neuropsychiatric disorder affecting many behaviors in daily life. Hyperactivity of the fronto-striato-thalamic circuit via the orbitofrontal cortex (OFC) is assumed to play a major role in the pathophysiology of OCD; however, its pathogenesis is not fully understood. Several reports have described the development of OCD after traumatic brain injury (TBI); however, the pathogenesis of post-TBI OCD remains unknown. Moreover, patients with TBI often have a variety of sequelae, including cognitive dysfunction and mood disorders, which make the diagnosis and treatment of OCD more complex.

Case presentation: We report the case of a 17-year-old Japanese male who developed OCD after traffic trauma. The patient developed a fear of contamination and checking compulsion after injuring his right OFC and left temporal lobe when he ran into a running truck during a suicide attempt. We believe that the patient's fear of contamination can be diagnosed as true post-TBI OCD. However, his memory impairment was significant, and we considered his checking compulsion to be strongly influenced by cognitive dysfunction due to TBI. We attempted behavioral therapy for OCD; however, sufficient results were not achieved because of the interference from the sequelae of TBI.

Conclusion: It is not rare for OCD symptoms to appear after TBI. Differentiating the OCD symptoms induced by brain injury or cognitive dysfunction associated with TBI is important to determine a treatment strategy.

背景介绍强迫症(OCD)是一种常见的神经精神障碍,影响日常生活中的许多行为。经由眶额皮层(OFC)的前三角-丘脑回路的过度活跃被认为在强迫症的病理生理学中起着重要作用;然而,其发病机制尚未完全明了。一些报告描述了创伤性脑损伤(TBI)后强迫症的发展情况;然而,创伤性脑损伤后强迫症的发病机制仍不清楚。此外,创伤性脑损伤患者往往伴有多种后遗症,包括认知功能障碍和情绪障碍,这使得强迫症的诊断和治疗更为复杂:我们报告了一例 17 岁日本男性交通创伤后患强迫症的病例。患者在一次自杀未遂的行动中撞上了一辆正在行驶的卡车,导致右侧大脑外叶和左侧颞叶受伤,之后便患上了污染恐惧和检查强迫症。我们认为,患者的污染恐惧可诊断为真正的创伤后强迫症。然而,他的记忆力明显受损,我们认为他的检查强迫症在很大程度上受到创伤后认知功能障碍的影响。我们尝试了强迫症行为疗法,但由于创伤后遗症的干扰,没有取得足够的效果:结论:创伤后出现强迫症症状并不罕见。结论:创伤后出现强迫症症状并不罕见,区分是脑损伤引起的强迫症症状还是创伤后遗症引起的认知功能障碍对于确定治疗策略非常重要。
{"title":"Obsessive-compulsive disorder after traumatic injury to the right frontal and left temporal lobes: A case report.","authors":"Daisuke Yoshioka, Takehiko Yamanashi, Teruaki Hayashi, Masaaki Iwata","doi":"10.1002/pcn5.199","DOIUrl":"10.1002/pcn5.199","url":null,"abstract":"<p><strong>Background: </strong>Obsessive-compulsive disorder (OCD) is a common neuropsychiatric disorder affecting many behaviors in daily life. Hyperactivity of the fronto-striato-thalamic circuit via the orbitofrontal cortex (OFC) is assumed to play a major role in the pathophysiology of OCD; however, its pathogenesis is not fully understood. Several reports have described the development of OCD after traumatic brain injury (TBI); however, the pathogenesis of post-TBI OCD remains unknown. Moreover, patients with TBI often have a variety of sequelae, including cognitive dysfunction and mood disorders, which make the diagnosis and treatment of OCD more complex.</p><p><strong>Case presentation: </strong>We report the case of a 17-year-old Japanese male who developed OCD after traffic trauma. The patient developed a fear of contamination and checking compulsion after injuring his right OFC and left temporal lobe when he ran into a running truck during a suicide attempt. We believe that the patient's fear of contamination can be diagnosed as true post-TBI OCD. However, his memory impairment was significant, and we considered his checking compulsion to be strongly influenced by cognitive dysfunction due to TBI. We attempted behavioral therapy for OCD; however, sufficient results were not achieved because of the interference from the sequelae of TBI.</p><p><strong>Conclusion: </strong>It is not rare for OCD symptoms to appear after TBI. Differentiating the OCD symptoms induced by brain injury or cognitive dysfunction associated with TBI is important to determine a treatment strategy.</p>","PeriodicalId":74405,"journal":{"name":"PCN reports : psychiatry and clinical neurosciences","volume":"3 2","pages":"e199"},"PeriodicalIF":0.0,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11177174/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between work environment changes due to the COVID-19 pandemic and post-traumatic stress disorder in Japanese workers during the emergency declaration. 在宣布紧急状态期间,COVID-19 大流行导致的工作环境变化与日本工人创伤后应激障碍之间的关系。
Pub Date : 2024-06-14 eCollection Date: 2024-06-01 DOI: 10.1002/pcn5.206
Tetsuro Noda, Kumi Hirokawa, Kyoko Tokunaga

Aim: This study investigated the association between COVID-19 pandemic-related work environment changes and suspected post-traumatic stress disorder (PTSD) in Japanese workers.

Methods: A web survey of 1104 workers was conducted in Japan between February 24 and March 2, 2021. The Japanese version of the Impact of Event Scale-Revised and questions regarding work environments and COVID-19 pandemic-related lifestyle changes were used.

Results: PTSD was suspected in 19.7% of respondents and was significantly higher in men (22.2%) than in women (17.2%). Being older and having an independent business were associated with decreased suspected PTSD risk. Longer online work hours, decreased sleep duration, and alcoholism were associated with increased suspected PTSD risk. When stratified by sex, long online work hours and fewer years of service were associated with increased suspected PTSD risk in men. An association between alcoholism and suspected PTSD was also observed in men. Younger age and decreased sleep duration were significantly associated with suspected PTSD in women.

Conclusion: Younger men with shorter work service duration were particularly vulnerable to pandemic-related PTSD, emphasizing the risks associated with long online work hours and alcoholism in men. Decreased sleep duration was a PTSD predictor in both sexes, suggesting its importance in PTSD prevention strategies for workers.

目的:本研究调查了 COVID-19 大流行相关工作环境变化与日本工人疑似创伤后应激障碍(PTSD)之间的关联:方法:2021 年 2 月 24 日至 3 月 2 日期间,在日本对 1104 名工人进行了网络调查。调查使用了日文版事件影响量表(Impact of Event Scale-Revised)以及有关工作环境和 COVID-19 大流行相关生活方式改变的问题:19.7%的受访者疑似患有创伤后应激障碍,男性(22.2%)明显高于女性(17.2%)。年龄越大和拥有独立企业与疑似创伤后应激障碍的风险越低有关。在线工作时间较长、睡眠时间减少和酗酒与疑似创伤后应激障碍风险增加有关。按性别分层后,在线工作时间长和工龄较短与男性疑似创伤后应激障碍风险增加有关。在男性中也观察到了酗酒与疑似创伤后应激障碍之间的关联。在女性中,年龄较轻和睡眠时间减少与疑似创伤后应激障碍有显著关联:结论:工作时间较短的年轻男性尤其容易患上与大流行相关的创伤后应激障碍,这强调了男性长时间在线工作和酗酒所带来的风险。睡眠时间缩短是预测男女创伤后应激障碍的一个因素,这表明睡眠时间缩短在工人创伤后应激障碍预防策略中的重要性。
{"title":"Association between work environment changes due to the COVID-19 pandemic and post-traumatic stress disorder in Japanese workers during the emergency declaration.","authors":"Tetsuro Noda, Kumi Hirokawa, Kyoko Tokunaga","doi":"10.1002/pcn5.206","DOIUrl":"10.1002/pcn5.206","url":null,"abstract":"<p><strong>Aim: </strong>This study investigated the association between COVID-19 pandemic-related work environment changes and suspected post-traumatic stress disorder (PTSD) in Japanese workers.</p><p><strong>Methods: </strong>A web survey of 1104 workers was conducted in Japan between February 24 and March 2, 2021. The Japanese version of the Impact of Event Scale-Revised and questions regarding work environments and COVID-19 pandemic-related lifestyle changes were used.</p><p><strong>Results: </strong>PTSD was suspected in 19.7% of respondents and was significantly higher in men (22.2%) than in women (17.2%). Being older and having an independent business were associated with decreased suspected PTSD risk. Longer online work hours, decreased sleep duration, and alcoholism were associated with increased suspected PTSD risk. When stratified by sex, long online work hours and fewer years of service were associated with increased suspected PTSD risk in men. An association between alcoholism and suspected PTSD was also observed in men. Younger age and decreased sleep duration were significantly associated with suspected PTSD in women.</p><p><strong>Conclusion: </strong>Younger men with shorter work service duration were particularly vulnerable to pandemic-related PTSD, emphasizing the risks associated with long online work hours and alcoholism in men. Decreased sleep duration was a PTSD predictor in both sexes, suggesting its importance in PTSD prevention strategies for workers.</p>","PeriodicalId":74405,"journal":{"name":"PCN reports : psychiatry and clinical neurosciences","volume":"3 2","pages":"e206"},"PeriodicalIF":0.0,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11177176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of routine repetitive transcranial magnetic stimulation on the sleep duration of patients with treatment-resistant depression: A prospective cohort study. 常规重复经颅磁刺激对耐药抑郁症患者睡眠时间的影响:前瞻性队列研究。
Pub Date : 2024-04-01 eCollection Date: 2024-06-01 DOI: 10.1002/pcn5.187
Khosro Sadeghniiat, Jayran Zebardast, Mohammadamin Parsaei, Homa Seyedmirzaei, Mohammad Arbabi, Ahmad Ali Noorbala, Sahar Ansari

Aim: The aim of this study was to evaluate the short-term and long-term effects of routine repetitive transcranial magnetic stimulation (rTMS) on the sleep duration, depressive symptoms, and quality of life of patients with treatment-resistant depression (TRD).

Methods: In this prospective cohort study, 25 participants with TRD were assessed using the Insomnia Severity Index (ISI) and four sleep duration components of the Pittsburgh Sleep Quality Index (PSQI). Depression severity was measured with Hamilton's Depression Rating Scale (HDRS) and Beck's Depression Inventory (BDI-II), and patient-perceived quality of life with the 36-Item Short-Form Survey (SF-36). All of these measures were evaluated at baseline (T0), and immediately (T1), 6 weeks (T2), and 12 weeks (T3) after the end of intervention.

Results: At T1 endpoint, HDRS, BDI, SF-36, ISI, and three PSQI items (time to wake up, time taken to fall asleep, and Real Sleep Time) significantly improved, though these gains were reduced at follow-up endpoints (T2 and T3). Adjusting for confounders (age, sex, occupational status, BMI, and hypnotic medication) revealed that only improvements in HDRS, BDI, and time taken to fall asleep at T1 remained statistically significant. Linear regression analyses showed no significant association between reduced time taken to fall asleep and depression symptoms, suggesting rTMS can independently enhance this parameter, irrespective of depression resolution.

Conclusion: Routine rTMS therapy can potentially enhance sleep duration in TRD individuals, alongside improved depressive symptoms and quality of life. However, these benefits tend to decrease over long-term follow-up, emphasizing a more pronounced short-term efficacy of rTMS.

目的:本研究旨在评估常规重复经颅磁刺激(rTMS)对难治性抑郁症(TRD)患者的睡眠时间、抑郁症状和生活质量的短期和长期影响:在这项前瞻性队列研究中,研究人员使用失眠严重程度指数(ISI)和匹兹堡睡眠质量指数(PSQI)的四个睡眠时间组成部分对25名TRD患者进行了评估。抑郁严重程度采用汉密尔顿抑郁评定量表(HDRS)和贝克抑郁量表(BDI-II)进行测量,患者感知的生活质量采用 36 项短表调查(SF-36)进行测量。所有这些指标均在基线(T0)、干预结束后立即(T1)、6 周(T2)和 12 周(T3)进行评估:结果:在T1终点,HDRS、BDI、SF-36、ISI和三个PSQI项目(起床时间、入睡时间和实际睡眠时间)均有显著改善,但在后续终点(T2和T3),这些改善有所减少。对混杂因素(年龄、性别、职业状况、体重指数和催眠药物)进行调整后发现,只有 HDRS、BDI 和入睡时间在 T1 阶段的改善仍具有统计学意义。线性回归分析表明,入睡时间的缩短与抑郁症状之间没有明显关联,这表明经颅磁刺激疗法可以独立提高这一参数,而与抑郁症的缓解无关:常规经颅磁刺激疗法有可能延长TRD患者的睡眠时间,同时改善抑郁症状和生活质量。然而,这些益处往往会在长期随访中逐渐减少,因此经颅磁刺激疗法的短期疗效更为显著。
{"title":"Effects of routine repetitive transcranial magnetic stimulation on the sleep duration of patients with treatment-resistant depression: A prospective cohort study.","authors":"Khosro Sadeghniiat, Jayran Zebardast, Mohammadamin Parsaei, Homa Seyedmirzaei, Mohammad Arbabi, Ahmad Ali Noorbala, Sahar Ansari","doi":"10.1002/pcn5.187","DOIUrl":"10.1002/pcn5.187","url":null,"abstract":"<p><strong>Aim: </strong>The aim of this study was to evaluate the short-term and long-term effects of routine repetitive transcranial magnetic stimulation (rTMS) on the sleep duration, depressive symptoms, and quality of life of patients with treatment-resistant depression (TRD).</p><p><strong>Methods: </strong>In this prospective cohort study, 25 participants with TRD were assessed using the Insomnia Severity Index (ISI) and four sleep duration components of the Pittsburgh Sleep Quality Index (PSQI). Depression severity was measured with Hamilton's Depression Rating Scale (HDRS) and Beck's Depression Inventory (BDI-II), and patient-perceived quality of life with the 36-Item Short-Form Survey (SF-36). All of these measures were evaluated at baseline (T0), and immediately (T1), 6 weeks (T2), and 12 weeks (T3) after the end of intervention.</p><p><strong>Results: </strong>At T1 endpoint, HDRS, BDI, SF-36, ISI, and three PSQI items (time to wake up, time taken to fall asleep, and Real Sleep Time) significantly improved, though these gains were reduced at follow-up endpoints (T2 and T3). Adjusting for confounders (age, sex, occupational status, BMI, and hypnotic medication) revealed that only improvements in HDRS, BDI, and time taken to fall asleep at T1 remained statistically significant. Linear regression analyses showed no significant association between reduced time taken to fall asleep and depression symptoms, suggesting rTMS can independently enhance this parameter, irrespective of depression resolution.</p><p><strong>Conclusion: </strong>Routine rTMS therapy can potentially enhance sleep duration in TRD individuals, alongside improved depressive symptoms and quality of life. However, these benefits tend to decrease over long-term follow-up, emphasizing a more pronounced short-term efficacy of rTMS.</p>","PeriodicalId":74405,"journal":{"name":"PCN reports : psychiatry and clinical neurosciences","volume":"3 2","pages":"e187"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11114370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141312464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suicide among national university graduate students in Japan from 2002 to 2021. 2002 至 2021 年日本国立大学研究生的自杀情况。
Pub Date : 2024-03-08 eCollection Date: 2024-03-01 DOI: 10.1002/pcn5.180
Toshiyuki Marutani, Katsuhiro Yasumi, Kenji Saito, Takehiro Ibaraki, Jun-Ya Takayama

Aim: Graduate students are exposed to various types of stress. Thus, they are prone to mental health problems, and the most devastating result is suicide. The aim of this paper is to reveal the status of suicide among graduate students in Japan for 20 years.

Methods: We analyzed cumulative data on suicide among national university graduate students from annual surveys on causes of non-graduation in Japan for the 2002-2003 through 2021-2022 academic years. We asked all national universities with graduate schools to complete the surveys, and the participation rate was 91.1%.

Results: The total number of students in the surveys was 2,383,858, and the number of deaths by suicide was 347 (292 males, 55 females). Chi-squared test results showed significantly higher suicide mortality rates for the following groups: male (p < 0.001), temporary leave (p < 0.001), repeating the same year (p = 0.006), master's level (p = 0.005), and majoring in engineering (p < 0.001). Psychiatric diagnoses were detected among 44 students (12.7%). The largest distribution (27 cases) of International Classification of Diseases, Tenth Revision (ICD-10) codes among those whose diagnoses were evident was F3, mood disorders. Estimated motives for suicide were reported for only 36 students (10.4%), of which the most prevalent was job search failure. The most prevalent suicide method was hanging (151 cases, 43.5%).

Conclusion: Our findings indicate that student support facilities should recognize higher-risk groups for suicide among graduate students. Our study adds suggestions for suicide prevention on campus during future pandemics.

目的:研究生面临各种压力。因此,他们很容易出现心理健康问题,而最严重的后果就是自杀。本文旨在揭示 20 年来日本研究生的自杀状况:我们分析了从 2002-2003 学年到 2021-2022 学年的日本国立大学研究生自杀原因年度调查的累积数据。我们要求所有设有研究生院的国立大学参与调查,参与率为 91.1%:参与调查的学生总数为 2,383,858 人,自杀死亡人数为 347 人(男性 292 人,女性 55 人)。卡方检验结果显示,以下群体的自杀死亡率明显较高:男生(P P = 0.006)、硕士生(P = 0.005)、工科专业(P 国际疾病分类第十次修订版(ICD-10)),其中诊断明显的代码为 F3,情绪障碍。只有 36 名学生(10.4%)报告了估计的自杀动机,其中最普遍的动机是求职失败。最常见的自杀方式是上吊(151 例,占 43.5%):我们的研究结果表明,学生支持机构应该认识到研究生中自杀风险较高的群体。我们的研究为未来流行病期间校园自杀预防工作提供了更多建议。
{"title":"Suicide among national university graduate students in Japan from 2002 to 2021.","authors":"Toshiyuki Marutani, Katsuhiro Yasumi, Kenji Saito, Takehiro Ibaraki, Jun-Ya Takayama","doi":"10.1002/pcn5.180","DOIUrl":"10.1002/pcn5.180","url":null,"abstract":"<p><strong>Aim: </strong>Graduate students are exposed to various types of stress. Thus, they are prone to mental health problems, and the most devastating result is suicide. The aim of this paper is to reveal the status of suicide among graduate students in Japan for 20 years.</p><p><strong>Methods: </strong>We analyzed cumulative data on suicide among national university graduate students from annual surveys on causes of non-graduation in Japan for the 2002-2003 through 2021-2022 academic years. We asked all national universities with graduate schools to complete the surveys, and the participation rate was 91.1%.</p><p><strong>Results: </strong>The total number of students in the surveys was 2,383,858, and the number of deaths by suicide was 347 (292 males, 55 females). Chi-squared test results showed significantly higher suicide mortality rates for the following groups: male (<i>p</i> < 0.001), temporary leave (<i>p</i> < 0.001), repeating the same year (<i>p</i> = 0.006), master's level (<i>p</i> = 0.005), and majoring in engineering (<i>p</i> < 0.001). Psychiatric diagnoses were detected among 44 students (12.7%). The largest distribution (27 cases) of <i>International Classification of Diseases, Tenth Revision</i> (ICD-10) codes among those whose diagnoses were evident was F3, mood disorders. Estimated motives for suicide were reported for only 36 students (10.4%), of which the most prevalent was job search failure. The most prevalent suicide method was hanging (151 cases, 43.5%).</p><p><strong>Conclusion: </strong>Our findings indicate that student support facilities should recognize higher-risk groups for suicide among graduate students. Our study adds suggestions for suicide prevention on campus during future pandemics.</p>","PeriodicalId":74405,"journal":{"name":"PCN reports : psychiatry and clinical neurosciences","volume":"3 1","pages":"e180"},"PeriodicalIF":0.0,"publicationDate":"2024-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11114341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141312726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of real-time VR clinical practice on reducing the stigma toward dementia among students of occupational therapy: A randomized controlled trial. 实时 VR 临床实践对减少职业治疗专业学生对痴呆症的偏见的影响:随机对照试验
Pub Date : 2023-12-03 eCollection Date: 2023-12-01 DOI: 10.1002/pcn5.160
Keita Ueno, Hiroyuki Tanaka, Kazuyuki Niki, Masaya Ueda, Ayumi Tanaka, Katsushi Yokoi, Yasuo Naito, Ryouhei Ishii

Aim: This study aimed to examine the effects of real-time online clinical practice using real-time virtual reality (VR) compared with 2D PC screening on reducing stigma toward dementia, and to investigate the feasibility of online clinical practice using VR.

Methods: A single-center, open-label, randomized controlled trial was conducted. Occupational therapy students were randomized to view occupational therapy evaluation screens for dementia patients using a VR headset or 2D monitor. The Attitudes Toward Dementia Scale (ADS), the Dementia Knowledge Scale (DKS), and Images of the Elderly with Dementia (IED) were assessed before and after the intervention. The level of clinical practice satisfaction and the System Usability Scale (SUS) were also assessed.

Results: The number of subjects in the intervention and control groups was 10 and 9, respectively. In ADS scores and IED, the main effect was shown in both groups and did not show interactions. In DKS scores, the main effect and interaction were not shown. The VR headset tended to be more usable than the 2D monitor in terms of usability. Satisfaction ratings indicated the characteristics of a realistic clinical experience through real-time VR viewing.

Conclusion: Real-time VR and 2D online clinical practice could reduce the stigma toward dementia, but there were no significant differences between the types. The real-time VR experience was more similar to actual clinical practice than a 2D PC screening due to the sense of immersion, but issues in blinding and lack of audio and video quality were found.

目的:本研究旨在探讨使用实时虚拟现实(VR)进行实时在线临床实践与二维电脑筛查相比,对减少痴呆症耻辱感的效果,并调查使用 VR 进行在线临床实践的可行性:方法:进行了一项单中心、开放标签、随机对照试验。职业治疗专业的学生被随机分配到使用 VR 头显或 2D 显示器查看痴呆症患者的职业治疗评估屏幕。在干预前后对痴呆症态度量表(ADS)、痴呆症知识量表(DKS)和痴呆症老人图像(IED)进行了评估。此外,还对临床实践满意度和系统可用性量表(SUS)进行了评估:干预组和对照组的受试者人数分别为 10 人和 9 人。在 ADS 评分和 IED 方面,两组均显示出主效应,且未出现交互作用。在 DKS 评分方面,主效应和交互效应均未显示。就可用性而言,VR 头显往往比 2D 显示器更可用。满意度评分表明,实时 VR 观看具有逼真临床体验的特点:结论:实时 VR 和 2D 在线临床实践可以减少对痴呆症的成见,但两种类型之间没有显著差异。与 2D PC 筛查相比,实时 VR 体验因其身临其境的感觉而更接近实际临床实践,但也发现了盲法和音视频质量不高的问题。
{"title":"Effects of real-time VR clinical practice on reducing the stigma toward dementia among students of occupational therapy: A randomized controlled trial.","authors":"Keita Ueno, Hiroyuki Tanaka, Kazuyuki Niki, Masaya Ueda, Ayumi Tanaka, Katsushi Yokoi, Yasuo Naito, Ryouhei Ishii","doi":"10.1002/pcn5.160","DOIUrl":"10.1002/pcn5.160","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to examine the effects of real-time online clinical practice using real-time virtual reality (VR) compared with 2D PC screening on reducing stigma toward dementia, and to investigate the feasibility of online clinical practice using VR.</p><p><strong>Methods: </strong>A single-center, open-label, randomized controlled trial was conducted. Occupational therapy students were randomized to view occupational therapy evaluation screens for dementia patients using a VR headset or 2D monitor. The Attitudes Toward Dementia Scale (ADS), the Dementia Knowledge Scale (DKS), and Images of the Elderly with Dementia (IED) were assessed before and after the intervention. The level of clinical practice satisfaction and the System Usability Scale (SUS) were also assessed.</p><p><strong>Results: </strong>The number of subjects in the intervention and control groups was 10 and 9, respectively. In ADS scores and IED, the main effect was shown in both groups and did not show interactions. In DKS scores, the main effect and interaction were not shown. The VR headset tended to be more usable than the 2D monitor in terms of usability. Satisfaction ratings indicated the characteristics of a realistic clinical experience through real-time VR viewing.</p><p><strong>Conclusion: </strong>Real-time VR and 2D online clinical practice could reduce the stigma toward dementia, but there were no significant differences between the types. The real-time VR experience was more similar to actual clinical practice than a 2D PC screening due to the sense of immersion, but issues in blinding and lack of audio and video quality were found.</p>","PeriodicalId":74405,"journal":{"name":"PCN reports : psychiatry and clinical neurosciences","volume":"2 4","pages":"e160"},"PeriodicalIF":0.0,"publicationDate":"2023-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11114262/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141312460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive review of multidimensional biomarkers in the ShangHai At Risk for Psychosis (SHARP) program for early psychosis identification 上海精神病风险(SHARP)项目中用于早期精神病识别的多维生物标志物的综合综述
Pub Date : 2023-11-14 DOI: 10.1002/pcn5.152
TianHong Zhang, LiHua Xu, XiaoChen Tang, YanYan Wei, YeGang Hu, HuiRu Cui, YingYing Tang, ChunBo Li, JiJun Wang
Abstract Psychosis is recognized as one of the largest contributors to nonfatal health loss, and early identification can largely improve routine clinical activity by predicting the psychotic course and guiding treatment. Clinicians have used the clinical high‐risk for psychosis (CHR) paradigm to better understand the risk factors that contribute to the onset of psychotic disorders. Clinical factors have been widely applied to calculate the individualized risks for conversion to psychosis 1–2 years later. However, there is still a dearth of valid biomarkers to predict psychosis. Biomarkers, in the context of this paper, refer to measurable biological indicators that can provide valuable information about the early identification of individuals at risk for psychosis. The aim of this paper is to critically review studies assessing CHR and suggest possible biomarkers for application of prediction. We summarized the studies on biomarkers derived from the findings of the ShangHai at Risk for Psychosis (SHARP) program, including those that are considered to have the most potential. This comprehensive review was conducted based on expert opinions within the SHARP research team, and the selection of studies and results presented in this paper reflects the collective expertise of the team in the field of early psychosis identification. The three dimensions with potential candidates include neuroimaging dimension of brain structure and function, electrophysiological dimension of event‐related potentials (ERPs), and immune dimension of inflammatory cytokines and complement proteins, which proved to be useful in supporting the prediction of psychosis from the CHR state. We suggest that these three dimensions could be useful as risk biomarkers for treatment optimization. In the future, when available for the integration of multiple dimensions, clinicians may be able to obtain a comprehensive report with detailed information of psychosis risk and specific indications about preferred prevention.
精神病被认为是造成非致死性健康损失的最大因素之一,早期识别可以通过预测精神病病程和指导治疗在很大程度上改善常规临床活动。临床医生已经使用临床精神病高风险(CHR)范式来更好地理解导致精神障碍发病的危险因素。临床因素被广泛应用于计算1-2年后转化为精神病的个体化风险。然而,仍然缺乏有效的生物标志物来预测精神病。在本文中,生物标志物指的是可测量的生物指标,这些指标可以为早期识别有精神病风险的个体提供有价值的信息。本文的目的是对评估CHR的研究进行批判性回顾,并提出可能用于预测的生物标志物。我们总结了来自上海精神病风险(SHARP)项目结果的生物标志物研究,包括那些被认为最有潜力的生物标志物。这项综合审查是基于SHARP研究团队内部的专家意见进行的,本文中所选择的研究和结果反映了该团队在早期精神病鉴定领域的集体专业知识。具有潜在候选的三个维度包括脑结构和功能的神经影像学维度,事件相关电位(ERPs)的电生理维度以及炎症细胞因子和补体蛋白的免疫维度,这些维度被证明有助于从CHR状态预测精神病。我们建议这三个维度可以作为治疗优化的风险生物标志物。在未来,当可以整合多个维度时,临床医生可能能够获得一份全面的报告,其中包含精神病风险的详细信息和首选预防的具体适应症。
{"title":"Comprehensive review of multidimensional biomarkers in the ShangHai At Risk for Psychosis (SHARP) program for early psychosis identification","authors":"TianHong Zhang, LiHua Xu, XiaoChen Tang, YanYan Wei, YeGang Hu, HuiRu Cui, YingYing Tang, ChunBo Li, JiJun Wang","doi":"10.1002/pcn5.152","DOIUrl":"https://doi.org/10.1002/pcn5.152","url":null,"abstract":"Abstract Psychosis is recognized as one of the largest contributors to nonfatal health loss, and early identification can largely improve routine clinical activity by predicting the psychotic course and guiding treatment. Clinicians have used the clinical high‐risk for psychosis (CHR) paradigm to better understand the risk factors that contribute to the onset of psychotic disorders. Clinical factors have been widely applied to calculate the individualized risks for conversion to psychosis 1–2 years later. However, there is still a dearth of valid biomarkers to predict psychosis. Biomarkers, in the context of this paper, refer to measurable biological indicators that can provide valuable information about the early identification of individuals at risk for psychosis. The aim of this paper is to critically review studies assessing CHR and suggest possible biomarkers for application of prediction. We summarized the studies on biomarkers derived from the findings of the ShangHai at Risk for Psychosis (SHARP) program, including those that are considered to have the most potential. This comprehensive review was conducted based on expert opinions within the SHARP research team, and the selection of studies and results presented in this paper reflects the collective expertise of the team in the field of early psychosis identification. The three dimensions with potential candidates include neuroimaging dimension of brain structure and function, electrophysiological dimension of event‐related potentials (ERPs), and immune dimension of inflammatory cytokines and complement proteins, which proved to be useful in supporting the prediction of psychosis from the CHR state. We suggest that these three dimensions could be useful as risk biomarkers for treatment optimization. In the future, when available for the integration of multiple dimensions, clinicians may be able to obtain a comprehensive report with detailed information of psychosis risk and specific indications about preferred prevention.","PeriodicalId":74405,"journal":{"name":"PCN reports : psychiatry and clinical neurosciences","volume":"39 41","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134953916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anorexia nervosa in a postoperative patient with Ebstein's anomaly Ebstein异常术后神经性厌食症1例
Pub Date : 2023-11-14 DOI: 10.1002/pcn5.154
Kengo Sato, Ryosuke Watanabe, Tsuyoshi Okada, Yasushi Nishiyori, Toshiyuki Kobayashi, Shiro Suda
Abstract Background Along with the improved prognosis of patients with congenital heart disease, the associated diverse complications are under scrutiny. Due to various medical restrictions on their upbringing, patients with congenital heart disease often have coexisting mental disorders. However, reports on patients with congenital heart disease and coexisting eating disorders are rare. Here, we report the case of a patient who developed anorexia nervosa (AN) following surgery for Ebstein's anomaly. Case Presentation A 21‐year‐old female with Ebstein's anomaly who underwent Fontan surgery was transferred to our institution with suspected AN after >2 years of intermittent stays at a medical hospital for decreased appetite. Initially, she did not desire to lose weight or fear obesity, and we suspected that she was suffering from appetite loss due to a physical condition associated with Fontan circulation. However, the eating disorder pathology gradually became more apparent. Conclusion Our experience suggests that patients with congenital heart disease are more likely to have a psychological background and physical problems that might contribute to eating disorders than the general population.
背景随着先天性心脏病患者预后的改善,相关的各种并发症正在受到关注。由于成长过程中的各种医疗限制,先天性心脏病患者往往同时存在精神障碍。然而,关于先天性心脏病和饮食失调并存的患者的报道很少。在这里,我们报告一个病人谁发展神经性厌食症(AN)手术后,Ebstein的异常。一例21岁Ebstein异常女性患者因食欲下降在医院间歇性住院2年后,因疑似AN而行Fontan手术转至我院。最初,她不希望减肥或害怕肥胖,我们怀疑她因与Fontan循环相关的身体状况而食欲不振。然而,饮食失调的病理逐渐变得更加明显。结论:我们的经验表明,先天性心脏病患者比一般人群更容易有可能导致饮食失调的心理背景和身体问题。
{"title":"Anorexia nervosa in a postoperative patient with Ebstein's anomaly","authors":"Kengo Sato, Ryosuke Watanabe, Tsuyoshi Okada, Yasushi Nishiyori, Toshiyuki Kobayashi, Shiro Suda","doi":"10.1002/pcn5.154","DOIUrl":"https://doi.org/10.1002/pcn5.154","url":null,"abstract":"Abstract Background Along with the improved prognosis of patients with congenital heart disease, the associated diverse complications are under scrutiny. Due to various medical restrictions on their upbringing, patients with congenital heart disease often have coexisting mental disorders. However, reports on patients with congenital heart disease and coexisting eating disorders are rare. Here, we report the case of a patient who developed anorexia nervosa (AN) following surgery for Ebstein's anomaly. Case Presentation A 21‐year‐old female with Ebstein's anomaly who underwent Fontan surgery was transferred to our institution with suspected AN after &gt;2 years of intermittent stays at a medical hospital for decreased appetite. Initially, she did not desire to lose weight or fear obesity, and we suspected that she was suffering from appetite loss due to a physical condition associated with Fontan circulation. However, the eating disorder pathology gradually became more apparent. Conclusion Our experience suggests that patients with congenital heart disease are more likely to have a psychological background and physical problems that might contribute to eating disorders than the general population.","PeriodicalId":74405,"journal":{"name":"PCN reports : psychiatry and clinical neurosciences","volume":"42 15","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134953445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A multicenter, double‐blind, randomized, controlled study of patients with treatment‐resistant schizophrenia treated with yokukansan for 12 weeks 一项多中心、双盲、随机、对照研究,研究对象是接受yokukansan治疗12周的难治性精神分裂症患者
Pub Date : 2023-11-14 DOI: 10.1002/pcn5.155
Jun Horiguchi, Rei Wake, Kenta Murotani, Haruo Seno, Tsuyoshi Miyaoka, Ken Inoue
Abstract Aim We conducted a 12‐week double‐blind, placebo‐controlled, multicenter study to evaluate the efficacy and safety of yokukansan in patients with schizophrenia. Methods Patients with schizophrenia resistant to antipsychotics whose Positive and Negative Syndrome Scale (PANSS) scores were stable within five points were enrolled and assigned to the yokukansan or placebo group. Fifty‐three of the 61 consenting patients were allocated to the yokukansan ( n = 27) and placebo ( n = 26) groups. Results The changes in total and positive PANSS scores at 12 weeks were significantly greater in the yokukansan group than in the placebo group. There were no significant changes in other psychiatric symptom rating scores in either group. Adverse reactions were reported in six of 27 patients (22.2%) in the yokukansan group and five of 26 patients (19.2%) in the placebo group, all of which were nonserious. Conclusion Yokukansan is very safe and has clinical potential as a treatment for schizophrenia in combination with Western medicine.
目的:我们进行了一项为期12周的双盲、安慰剂对照、多中心研究,以评估yokukansan对精神分裂症患者的疗效和安全性。方法将PANSS评分稳定在5分以内的抗精神病药耐药精神分裂症患者分为yokukansan组和安慰剂组。61名同意患者中的53名被分配到yokukansan组(n = 27)和安慰剂组(n = 26)。结果在12周时,横坎山组总PANSS评分和阳性PANSS评分的变化明显大于安慰剂组。两组的其他精神症状评分均无显著变化。yokukansan组27例患者中有6例(22.2%)报告了不良反应,安慰剂组26例患者中有5例(19.2%)报告了不良反应,均为非严重反应。结论横坎散与西药联合治疗精神分裂症安全可靠,具有临床应用潜力。
{"title":"A multicenter, double‐blind, randomized, controlled study of patients with treatment‐resistant schizophrenia treated with yokukansan for 12 weeks","authors":"Jun Horiguchi, Rei Wake, Kenta Murotani, Haruo Seno, Tsuyoshi Miyaoka, Ken Inoue","doi":"10.1002/pcn5.155","DOIUrl":"https://doi.org/10.1002/pcn5.155","url":null,"abstract":"Abstract Aim We conducted a 12‐week double‐blind, placebo‐controlled, multicenter study to evaluate the efficacy and safety of yokukansan in patients with schizophrenia. Methods Patients with schizophrenia resistant to antipsychotics whose Positive and Negative Syndrome Scale (PANSS) scores were stable within five points were enrolled and assigned to the yokukansan or placebo group. Fifty‐three of the 61 consenting patients were allocated to the yokukansan ( n = 27) and placebo ( n = 26) groups. Results The changes in total and positive PANSS scores at 12 weeks were significantly greater in the yokukansan group than in the placebo group. There were no significant changes in other psychiatric symptom rating scores in either group. Adverse reactions were reported in six of 27 patients (22.2%) in the yokukansan group and five of 26 patients (19.2%) in the placebo group, all of which were nonserious. Conclusion Yokukansan is very safe and has clinical potential as a treatment for schizophrenia in combination with Western medicine.","PeriodicalId":74405,"journal":{"name":"PCN reports : psychiatry and clinical neurosciences","volume":"42 21","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134953442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
PCN reports : psychiatry and clinical neurosciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1